Enhanced inhibition of tumor growth with depletion of CD25 regulatory cells and intratumoral immunization with tumor RNA-pulsed dendritic cells in a C57BL/6 pancreatic tumor model.
Linke
Andrea
A
Brossart
Peter
P
Schmidt-Wolf
Ingo G H
IG
Gonzalez-Carmona
Maria A
MA
Ziske
Carsten
C
Messmer
Davorka
D
Schmitz
Volker
V
Sauerbruch
Tilman
T
D000818:Animals; D000906:Antibodies / Q000008:administration & dosage* / Q000276:immunology; D045744:Cell Line, Tumor; D003131:Combined Modality Therapy; D003713:Dendritic Cells / Q000166:cytology / Q000276:immunology* / Q000637:transplantation; D005260:Female; D016219:Immunotherapy, Adoptive / Q000379:methods; D053645:Interleukin-2 Receptor alpha Subunit / Q000276:immunology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010190:Pancreatic Neoplasms / Q000473:pathology / Q000628:therapy*; D012334:RNA, Neoplasm / Q000276:immunology*; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome; D047368:Tumor Burden / Q000187:drug effects / Q000276:immunology
D000906:Antibodies; D053645:Interleukin-2 Receptor alpha Subunit; D012334:RNA, Neoplasm